# A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium

> **NCT01242579** · PHASE1 · WITHDRAWN · sponsor: **International Partnership for Microbicides, Inc.**

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Maraviroc/Dapivirine Gel
- **DRUG:** Dapivirine Vaginal Gel
- **DRUG:** Maraviroc Vaginal Gel
- **DRUG:** Matching Placebo Gel

## Key facts

- **NCT ID:** NCT01242579
- **Lead sponsor:** International Partnership for Microbicides, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** In order to focus efforts on the combination ring formulation, IPM decided not to move forward with this trial.
- **Last updated:** 2011-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01242579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01242579, "A Safety and Pharmacokinetic Study for Dapivirine and Maraviroc Gel in Belgium". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01242579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*